Medical Devices
-
Justin Sullivan via Getty Images
California AG sues over 23andMe data breach
The attorney general said the civil penalties could add up to “multiple millions” if the suit is successful.
By Elise Reuter • May 29, 2026 -
Courtesy of Johnson & Johnson
J&J recalls Impella heart pumps after patient dies
Johnson & Johnson asked customers to quarantine and return affected products. A spokesperson said J&J conducted quality system audits as part of its integration of Abiomed that resulted in some field actions.
By Nick Paul Taylor • May 29, 2026 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Courtesy of Ōura
Ōura to add blood pressure feature following FDA policy change
The new wellness tool would alert users to signs of increasing blood pressure. Ōura is studying a separate feature to flag hypertension that would go through the Food and Drug Administration.
By Elise Reuter • May 28, 2026 -
Courtesy of Siemens Healthineers
Siemens Healthineers, AiM team up; Procept completes study enrollment
Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept finished enrollment in a study of its aquablation treatment in prostate cancer.
By Susan Kelly • May 28, 2026 -
Courtesy of Abbott
Abbott receives CE mark for dual glucose-ketone sensor
Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.
By Elise Reuter • May 27, 2026 -
Courtesy of Cornerstone Robotics
Cornerstone earns Europe’s CE mark for surgical robot
CE mark certification comes after Hong Kong-based Cornerstone Robotics raised $200 million in November to accelerate its global expansion.
By Susan Kelly • May 27, 2026 -
Courtesy of Insulet
Insulet recalls 7M patch pumps due to leak risk
The recall is Insulet’s second this year related to tears in the device tubing. So far, 24 serious adverse events have been reported.
By Elise Reuter • May 27, 2026 -
Mario Tama via Getty Images
J&J’s DePuy Synthes inks deal to buy orthopedic surgery tech
The acquisition is the latest in a series of agreements between DePuy Synthes and organizations associated with entrepreneur Stéphane Lavallée.
By Nick Paul Taylor • May 27, 2026 -
Courtesy of Dexcom
Dexcom warns of scrapped glucose sensors being resold
Dexcom has identified two lots of G7 sensors that have been stolen, sold and used by customers.
By Elise Reuter • Updated May 27, 2026 -
Mario Tama via Getty Images
J&J corrects Impella controller over issue linked to 2 injuries, 1 death
The controller can stop for about 35 seconds, during which time the patient is unsupported by the heart pump.
By Nick Paul Taylor • May 26, 2026 -
Courtesy of Olympus
Olympus expands in cancer tech with $270M buy of BioProtect
BioProtect’s balloon spacer device separates the prostate from other structures during cancer radiation.
By Susan Kelly • May 26, 2026 -
Courtesy of Beta Bionics
Beta Bionics to launch its first insulin patch pump to compete with Insulet
The device called Mint, which would work with the company’s adaptive insulin dosing algorithm, is expected to debut in the first half of 2027.
By Elise Reuter • May 26, 2026 -
Retrieved from Medtronic on May 11, 2026
Medtronic to create European software hub in Ireland
The investment in cardiac digital health will add 85 jobs initially, with more growth expected over the next three years.
By Susan Kelly • May 22, 2026 -
Courtesy of Intuitive Surgical
Intuitive readies 100 updates and improvements for da Vinci 5
Some updates to Intuitive’s surgical robot aim to improve communication between remote and on-site physicians to expand education opportunities.
By Nick Paul Taylor • May 22, 2026 -
Courtesy of Sentante
Sentante lands Europe’s CE mark for endovascular robot
The Lithuania-based robotic surgery company is advancing a remote stroke system that was accepted into the FDA’s total product life cycle advisory program earlier this year.
By Susan Kelly • May 21, 2026 -
Courtesy of Medtronic
Medtronic to buy SPR Therapeutics for about $650M
Medtronic would gain a treatment for chronic pain management in its third major acquisition this year.
By Elise Reuter • May 20, 2026 -
Courtesy of Medtronic
Medtronic data back renal denervation in the long term
Analyses presented at EuroPCR assessed Medtronic’s Symplicity blood pressure procedure in patient groups with severe hypertension and who had prior cardiovascular events.
By Susan Kelly • May 20, 2026 -
Getty Images
Endologix buys clot removal system from Surmodics
Endologix will market the system to vascular interventionists who use its other devices to treat peripheral artery disease and abdominal aortic aneurysms.
By Nick Paul Taylor • May 20, 2026 -
Courtesy of BD
Medtronic, BD name new leaders
Kweli Thompson will be promoted to head of Medtronic’s neuroscience portfolio, and Peter Menziuso will join BD’s interventional business.
By Elise Reuter • May 19, 2026 -
Courtesy of Boston Scientific
Boston Scientific posts positive data for coronary IVL catheter
With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for patients with severely calcified coronary artery disease.
By Susan Kelly • May 19, 2026 -
Getty Images
Artivion closes Endospan buyout to acquire recently approved heart device
Artivion is targeting a $150 million annual U.S. market for the Nexus Aortic Arch System.
By Nick Paul Taylor • May 19, 2026 -
Courtesy of Boston Scientific
Boston Scientific buys $1.5B stake in TAVR developer MiRus
The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional payments totaling $3 billion.
By Susan Kelly • May 18, 2026 -
Permission granted by Embecta
Embecta closes Owen Mumford acquisition for up to $201M
Embecta bought the company, which has an auto-injector platform, to expand outside of diabetes care.
By Elise Reuter • May 18, 2026 -
Permission granted by Dexcom
Dexcom to add 2 board directors with activist investor Elliott
CEO Jake Leach also discussed the company’s plans for its G8 glucose sensor, dual-analyte sensing and Medicare coverage at an investor day.
By Elise Reuter • May 15, 2026 -
Courtesy of Carl Zeiss Meditec
Carl Zeiss says restructuring could affect up to 1,000 jobs
A weak investment climate in the Americas contributed to declines in the German company’s intraocular lens business in the first half of its fiscal year.
By Susan Kelly • May 15, 2026
